Area | Product | Company | Services |
| | | |
Oncology | Proleukin (aldesleukin, recombinant interleukin, iL-2) | Chiron Novartis | AP/ME/CE/ IM/MM//PR/ PU |
Oncology | Cardioxan (dexrazoxane, ICRF-187) | Chiron Novartis | AP/ME/CE/ IM/MM/PR/ PU |
Oncology | Salagen (pilocarpine HCI) | Chiron Novartis MGI Pharma Eisai Corporation | AP/ME/ CE/IM/ MM/PR/ PU |
Oncology | OncoScint CR 103 (Mab B72.3-GYK-DTPA 1 mg/2ml) | Chiron Novartis | AP/ME/CE/ IM/MM/PR/ PU |
Autoimmune Disease/CNS | Betaseron/Betaferon | Chiron/Novartis Berlex/Schering AG Bayer Schering AG | ME/CE/PU |
Infectious Diseases (HIV/AIDS) | Tenofovir Disoproxil Fumarate (Tenofovir DS) | Gilead Sciences | AP/ME/CE/ ED/PR/MM/ IM/PU |
Infectious Diseases | Adefovir Dipivoxil | Gilead Sciemces | AP/ME/CE/ ED/PR/MM/ IM/PU |
Infectious Diseases (systemic fungal infections) | AmBisome (liposomal Amphotericin B) | Nexstar Pharmaceuticals Gilead Sciences | AP/ME/CE /EDPR/MM/ IM/PU |
Oncology | DaunoXome (daunorubicin citrate liposome injection) | Nexstar Pharmaceuticals Gilead Sciences | AP/ME/CE/ ED/PR/MM/ IM/PU |
Oncology | Aromasin (exemestane) | Pharmacia Oncology Pfizer | AP/ME/CE /ED/MM/IM/ PU |
Oncology | Farmorubicine/Pharmorubicin (epirubicine) | Pharmacia Oncology Pfizer | AP/ME/CE/ ED/MM/IM/ PU |
Oncology | Celebrex (celecoxib, COX-2) | Pharmacia Oncology Pfizer | AP/ME/CE/ ED/MM/IM/ PU |
Oncology | Roferon-A (interferon alfa-2a) | Roche | ME/CE/MM/ PU |
Oncology | Xeloda (capecitabine) | Roche | ME/CE/MM |
Oncology/ Hematology | NeoRecormon (epoetin beta) | Roche | ME/CE/MM |
Oncology | Mabthera (rituximab) | Roche | ME/CE/MM |
Oncology | Trastuzumab (herceptin) | Roche Genentech | ME/CE |
Oncology | Avastin (bevacizumab) | Roche Genentech | ME/CE |
Oncology/ Rheumatology | Rituxan (rituximab) | Genentech Biogen IDEC | ME/CE/ED |
Oncology/ Hematology | Aranesp (darbepoetin alfa) | Amgen Oncology | ME/CE |
Oncology | Taxotere (docetaxel) | Sanofi Aventis | ME/CE/ PU/MM |
Oncology | Eloxatin (oxaliplatin for injection) | Sanofi Aventis | ME/CE/ PU/MM |
Oncoogy | Oncophage (vitespen, HSPPC-96) | Antigenics | AP/ME/CE IM/MM |
Oncology | Aroplatin (liposomal platinum agent) | Antignics | ME/CE IM/MM |
Oncology | Clolar (clofarabine) | Genzyme Oncology | AP/ME |
Lysosomal Storage Disorders | Cerezyme (imiglucerase for injection) | Genzyme | ME/CE |
Lysosomal Storage Disorders | Fabrazyme (agalsidase beta) | Genzyme | ME/CE |
Renal Disease | Renagel (sevelamer hydrocholride) | Genzyme | ME/CE |
Infectious Diseases (HIV/AIDS) | Kaletra (lopinavir/ritonavir) | Abbott Virology | ME/CE/PU |
Infectious Diseases(HIV/AIDS) | Norvir (ritonavir) | Abbott International | ME/CE/PU |
Oncology | Femara (letrozole) | Novartis | ME/CE |
Oncology | Gleevec/Glivec (imatinib mesylate) | Novartis | AP/ME/CE |
Infectious Diseases/ Vaccines | Priorix | GSK/SmithKline Beecham Biologicals | AP/ME/CE |
Infectious Diseases/ Vaccines | Infanrix | GSK/SmithKline Beecham Biologicals | AP/ME/CE |
Oncology | Erbitux (cetuximab) | Merck KgA | AP/ME/CE ED/MM/PR |
Oncology | Nexavar (sorafenib) | Onyx Pharmaceuticals Bayer HealthCare Pharmaceuticals | AP/ME/ED/ MM |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |